Correlation between Immunohistochemical Markers in Hepatocellular Carcinoma Cells and In Vitro High-Throughput Drug Sensitivity Screening

Correlation between Immunohistochemical Markers in Hepatocellular Carcinoma Cells and In Vitro High-Throughput Drug Sensitivity Screening

Aim. This study analyzed the correlation between immunohistochemical markers in hepatocellular carcinoma cells and the results of in vitro high-throughput drug sensitivity screening, to provide a reference for individualized drug treatment in patients with liver cancer. Methods. Seventy-four patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guo-Ying Feng, Yu Cheng, Kai Chen, Zheng-Rong Shi
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2022/5969716
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrating molecular, biochemical, and immunohistochemical features as predictors of hepatocellular carcinoma drug response using machine-learning algorithms
by: Marwa Matboli, et al.
Published: (2024-10-01)

Screening for Hepatocellular Carcinoma
by: Hock-Foong Lui
Published: (2011-01-01)

SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment
by: Eundong Park, et al.
Published: (2025-04-01)

Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma
by: Liang Qu, Vaisnavi Thirugnanasundralingam, Damien Bolton, Antonio Finelli, Nathan Lawrentschuk
Published: (2020-10-01)

CD34 Angiogenesis Marker in Oral Squamous Cell Carcinoma: An Immunohistochemical Study
by: Vijayalaxmi, et al.
Published: (2025-04-01)

Radiomics predicting immunohistochemical markers in primary hepatic carcinoma: Current status and challenges
by: Yunqing Yin, et al.
Published: (2024-12-01)

PROGNOSTIC ROLE OF LABORATORY AND IMMUNOHISTOCHEMICAL MARKERS IN THE RECURRENCE OF ORAL MUCOSAL SQUAMOUS CELL CARCINOMA
by: S. L. Kutukova, et al.
Published: (2015-04-01)

The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01)

CD105 as a Marker of Angiogenesis in Oral Squamous Cell Carcinoma – An Immunohistochemical Study
by: Vijayalaxmi, et al.
Published: (2025-04-01)

Clinicopathological correlation and expression of PD-L1 in cervical carcinoma: An immunohistochemical study
by: Arshdeep Kaur, et al.
Published: (2024-12-01)

TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma
by: Ying Xu, et al.
Published: (2025-04-01)

Application of immunohistochemical markers in mycosis fungoides
by: SHAO Kaixin, et al.
Published: (2025-01-01)

Beclin-1 as a potential prognostic marker in correlation with E-cadherin in oral lichen planus and oral squamous cell carcinoma: an immunohistochemical analysis
by: Heba N. Shalash, et al.
Published: (2024-12-01)

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications
by: Longhui Xie, et al.
Published: (2025-04-01)

Rapid and reproducible generation of glioblastoma spheroids for high-throughput drug screening
by: Christian Bach, et al.
Published: (2024-12-01)

Mechanisms of drug resistance in hepatocellular carcinoma
by: Yongchun Zou, et al.
Published: (2025-05-01)

Hepatocellular carcinoma drug resistance models
by: Xiaolu Xie, et al.
Published: (2025-05-01)

An improved single cell ultrahigh throughput screening method based on in vitro compartmentalization.
by: Fuqiang Ma, et al.
Published: (2014-01-01)

Deep learning guided high-throughput virtual screening for in vitro antibody maturation
by: Gong Chen, et al.
Published: (2025-01-01)

Relationship between immunohistochemical markers and clinical pathological variables in clear cell renal cell carcinoma
by: Pengshuai Liu, et al.
Published: (2025-08-01)

Immunohistochemical Analysis of p63 Marker Expression in Pleomorphic Adenoma and Mucoepidermoid Carcinoma of Salivary Gland
by: Mahmood Jahangirnezhad, et al.
Published: (2012-11-01)

Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
by: Yan Lu, et al.
Published: (2020-10-01)

Immunohistochemical analysis of angiogenesis in invasive ductal breast carcinoma with correlations to clinic pathological factor
by: Ivković-Kapicl Tatjana, et al.
Published: (2006-01-01)

Immunohistochemical expression of PD-L1 in esophageal carcinoma and its correlation with histopathological features
by: Tarunpreet Saini, et al.
Published: (2024-10-01)

Immunohistochemical Expression of p53 in Epithelial Ovarian Carcinoma and Its Correlation with Clinicopathological Parameters
by: Farzana Sharmin, et al.

Presence of Merkel cell polyomavirus DNA and large-T antigen in keratinocyte carcinomas and its correlation with immunohistochemical markers p16, p53 and ki67
by: T.R. Bellott, et al.
Published: (2024-09-01)

Random PCR and ultracentrifugation increases sensitivity and throughput of VIDISCA for screening of pathogens in clinical specimens
by: Le Van Tan, et al.
Published: (2010-07-01)

Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”
by: Wei Chen, et al.
Published: (2025-07-01)

Immunohistochemical study of proinflammatory markers in periapical lesions
by: Heba Faiz Hamodat
Published: (2025-03-01)

Serum-biomarker-based population screening model for hepatocellular carcinoma
by: Wenmin Liao, et al.
Published: (2025-03-01)

Histological and Immunohistochemical Revision of Hepatocellular Adenomas: A Learning Experience
by: S. Fonseca, et al.
Published: (2013-01-01)

SLC25A19 is a key prognostic marker for hepatocellular carcinoma
by: Liang Chen, et al.
Published: (2025-04-01)

Comparison of immunohistochemical characteristics of prognostic markers expression in non-metastatic and metastatic invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2016-10-01)

Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis
by: Miaomiao Li, et al.
Published: (2025-04-01)

Machine learning developed LKB1-AMPK signaling related signature for prognosis and drug sensitivity in hepatocellular carcinoma
by: Wang Li, et al.
Published: (2025-07-01)

AI enhanced diagnostic accuracy and workload reduction in hepatocellular carcinoma screening
by: Rui-Fang Lu, et al.
Published: (2025-08-01)

High-throughput strategies for monoclonal antibody screening: advances and challenges
by: Xiao-Dong Wang, et al.
Published: (2025-05-01)

Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library
by: Kalenahalli Rajappa Harisha, et al.
Published: (2025-07-01)

Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs
by: G. V. Zhukova, et al.
Published: (2024-09-01)

Immunohistochemical profile and molecular markers of lung carcinoma in tertiary care medical center - A retrospective observational study
by: Bhagiradhi Thimmapuram, et al.
Published: (2025-05-01)